• 08:00
• 

• Registration & Refreshments

  Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It's the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event

• 08:50
• 

• Welcome Address & Chairperson’s opening remarks

  Begin your conference journey with a warm welcome from our esteemed Chairperson

  ---

  

  Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
  eMQT

Enhancing Efficiency through Streamlined Clinical Trials

• 09:00
• 

• Tactical and Strategic Use of AI in Clinical Trials

  The integration of AI in the planning and conduct of clinical trials is gaining significant attention in the biopharmaceutical industry. This keynote presentation will provide a comprehensive exploration of tactical and strategic applications of AI in the design, execution, and analysis and reporting of clinical trials and across the clinical development lifecycle. Moreover, it will highlight the impact of AI on the roles within clinical development, providing insights into the evolving landscape of the industry. This presentation will offer a compelling and thought-provoking perspective of the transformative potential of AI in clinical development.

    Presentation

  ---

  

  Richardus Vonk VP, Head of Oncology Data Analytics and Statistical Sciences
  Bayer AG

  Clinical Trial Innovation Innovation and Technology Integration

• 09:30
• 

• Integrating Blockchain into clinical research

    Presentation

  ---

  

  Jose Manuel Cervera Grau Executive Director
  Eli Lilly and Company

  Innovation and Technology Integration

• 10:00
• 

• Innovating with AI: digital transformations for clinical research

  Clinical trials are one of the most expensive parts of the drug development process; thus one of the goals of clinical trial professionals is to increase efficiency along the process. There is a huge amount of excitement around new innovations in AI technology, but it's not always easy to cut through the noise and find out where these innovations can really bring value to clinical research. In this talk, we will provide an overview of some of the latest innovations in AI & NLP (natural language processing), for translation, privacy, and insights, and showcase recent use cases from pharma and healthcare customers.

    Presentation

  ---

  

  Jane Reed Director of Life Sciences NLP
  Linguamatics

• 10:30
• 

• Ensuring Compliance and Inspection Readiness Through Effective Risk Management

    Presentation

  ---

  

  Miguel Valenzuela Associate Director Clinical Operations - RBQM+
  Alnylam Pharmaceuticals

  Risk Management and Compliance

• 11:00
• 

• Business Card Exchange with Morning Coffee/Tea & Discussion

  Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections

   

       

• 11:20
• 

• Forging Successful Global Research Partnership in Southeast Asia - Universiti Malaya Medical Centre's Experience

  ---

  

  Prof. Dr. Ho Gwo Fuang Consultant clinical oncologist
  Clinical Investigation Centre, UMMC

  Partnerships and Collaboration Outsourcing & Clinical Trials

• 11:50
• 

• Advancing Patient Safety Through Inclusive Clinical Trials: Harnessing Real-World Data Directly from Source

    Presentation

  ---

  

  Martin Gibson Chief Medical Officer
  NorthWest EHealth

  Patient-Centric Approaches Data and Real-World Evidence

• 12:20
• 

• Digital Transformation: Developing and deploying a digital authoring platform across the value chain

    Presentation

  ---

  

  Waheed Jowiya Digitalisation Strategy Lead
  Novo Nordisk

  

  Louise Lind Skov Head of Content Digitalisation
  Novo Nordisk

• 12:45
• 

• Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths

  Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.

   

              

• 13:35
• 

• Increasing diversity in clinical trials in the UK: Results from a nationally representative survey

  ---

  

  Rebecca West Associate Director leading Global Health
  Ipsos

  Diversity and Inclusion in Clinical Trials

• 14:00
• 

• Patient Involvement and Patient Reported Outcomes. Does it make a difference?

    Presentation

  ---

  

  Regine Buffels Principal Global Medical Affairs Director
  Hoffmann-La Roche

  Patient-Centric Approaches Data and Real-World Evidence

• 14:30
• 

• End-to-End management of critical quality factors across a vaccine study/program

    Presentation

  ---

  

  Magali Traskine Associate Director, Central Monitoring
  GSK

  Patient-Centric Approaches Recruitment and Site Selection Quality Assurance and Monitoring

• 15:00
• 

• From EHR to Sponsor – harnessing electronic health records in clinical research

  ---

  

  Rebecca Jackson Senior Manager, R&D IT, Enabling Innovation
  Johnson & Johnson Technology

• 15:30
• 

• Recharge with Tea or Coffee While Networking

  Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.

   

       

• 15:50
• 

• Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment

  • Discover sites with a demonstrated track record of good execution in trials
  • Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
  • Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered.
  • Access to subject population with the required eligibility criteria
  • Network within industries

  ---

  

  Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
  eMQT

  

  Viraj Rajadhyaksha Area Medical Director
  AstraZeneca

  

  Diane Driver Head Program Delivery
  UCB

  

  Rasmus Hjorth Head of communication
  James Lind Care

  Patient-Centric Approaches Recruitment and Site Selection

• 16:20
• 

• The Role of Investigator-Initiated Trials in Leveraging Real-World Evidence

  ---

  

  Viraj Rajadhyaksha Area Medical Director
  AstraZeneca

  Data, Innovation & Technology Data and Real-World Evidence

• 16:50
• 

• Sponsor centric to Patient centric framework - Improving patient recruitment & enhancing their involvement

    Presentation

  ---

  

  Lucy Campbell Research Manager
  King's College London

  Patient-Centric Approaches Recruitment and Site Selection

• 17:20
• 

• Panel Discussion: The Future of Patient-Centricity in Clinical Trials - Embedding a patient-centric approach to clinical trial design

  • How to integrate patient feedback into clinical trial design effectively.
  • The role of digital health technologies in enhancing patient engagement and experience.
  • Strategies for maintaining communication and trust with participants throughout the trial.
  • The impact of patient-centric approaches on trial outcomes and drug development timelines.
  • Ethical considerations and data privacy in a patient-centered model.

  ---

  

  Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
  eMQT

  

  Sophie Wintrich Patient Advocacy Connector
  Patient Co-Next

  

  Diane Driver Head Program Delivery
  UCB

  

  Lukasz Wiech Chief Medical Officer
  European Clinical Trials Information Network

  Patient-Centric Approaches Innovation and Technology Integration Diversity and Inclusion in Clinical Trials

• 17:50
• 

• Interactive Breakout Round Table Discussion

  All the participants will have a great opportunity to discuss and explore a selection of most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.

  Table 1 - Revolutionizing Patient Recruitment: Strategies for Today’s Digital World 
  Exploring the intersection of digital marketing, social media, and patient advocacy in enhancing recruitment efficiency. 

  Table 2 - Mastering the Art of Site Selection: Balancing Technology, Geography, and Patient Access 
  Delving into the criteria and tools that can optimize site selection for diverse and technologically advanced clinical trials. 

  Table 3 - Harnessing Data Science: The New Frontier in Trial Design and Real-World Evidence 
  Discussing the transformative potential of big data analytics, AI, and real-world evidence in the design and execution of clinical trials. 

  Table 4 - The Evolving Landscape of Clinical Trial Regulations: Global Perspectives and Harmonization 
  Navigating the complexities of international regulatory environments and striving for a harmonized approach to global clinical trials. 

  Table 5- Patient-Centricity in Clinical Trials: More Than Just a Buzzword? 
  Evaluating the real-world application of patient-centric approaches in trial design, conduct, and outcomes.

  Table 6- Innovation in Trial Monitoring and Quality Assurance: Risk-Based Approaches and Beyond 
  Examining the latest methodologies in risk-based monitoring, quality by design, and the role of clinical auditing in ensuring trial integrity.

• 18:20
• 

• Chairperson’s Closing Remark

  End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.

• 18:30
• 

• Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations

  Wrap up the day with evening drinks and lively conversations. A relaxed setting to network, share insights from the day, and enjoy the company of fellow attendees.

• 08:30
• 

• Registration & Refreshments

  Start the second day of the conference by checking in and grabbing a morning refreshment. It’s a great opportunity to re-engage with peers, discuss the previous day’s insights, and prepare for another day of learning and networking.

• 08:50
• 

• Welcome Address & Chairperson’s opening remarks

  Start the second day with insightful remarks from our Chairperson

  ---

  

  Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
  eMQT

Shaping the Future with Innovative Trials

• 09:00
• 

• Personalized Clinical Trials Framework: Considerations for implementation from a patient centricity perspective

    Presentation

  ---

  

  Sophie Wintrich Patient Advocacy Connector
  Patient Co-Next

  

  Pauline Frank Chief Patient Connector
  Patient Co-Next

  Data, Innovation & Technology Patient-Centric Approaches

• 09:30
• 

• Roche Rater Academy: An enterprise wide approach to developing a rater training lifecycle to improve rater data quality, productivity and inclusivity for an improved customer experience enabled through a strategic supplier partnership

  • Aligned Rater certification standards across Roche studies to unlock opportunity to leverage Raters across studies/programs
  • Enabling multiple qualification pathways tailored to site rater experience
  • Centralization of rater training and certification process enabling insights to drive decision making
    Presentation

  ---

  

  Jennifer Eyerman Clinical Trial Partner, Clinical Operations, Research and Early Development
  Roche

  Innovation and Technology Integration Outsourcing & Clinical Trials

• 10:00
• 

• New opportunities for patient recruitment and diversity – Conducting clinical trials in the MENA region

  ---

  

  Rohan Simon Associate Director - Business Development
  Insights Research Organization & Solutions

• 10:30
• 

• Data-Enabled Recruitment to Clinical Trials and How Real-World Data Can Enhance Clinical Trial Outcomes and Safety Monitoring

    Presentation

  ---

  

  Tim Williams Head of Interventional Research - CPRD
  Medicines and Healthcare products Regulatory Agency

  Clinical Trial Innovation Recruitment and Site Selection

• 11:00
• 

• Business Card Exchange with Morning Coffee/Tea & Discussion

  Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections.

   

       

• 11:20
• 

• Empowering Clinical Research with Artificial Intelligence: Unlocking the Value of Real-World Data

  ---

  

  Gabriel Maeztu Co-Founder & President
  IOMED

  Innovation and Technology Integration Clinical Data & Tech Driven Clinical Trials

• 11:45
• 

• Planning and Placement: A recipe for research delivery success

  • Plan for success. Find out ways to involve patients in your trial design and acquire feedback from KOLs prior to regulatory approvals
  • Understand how we can work with you to confidently place your research in the right setting and sites in the UK
    Presentation

  ---

  

  Karen Matthews Senior Business Development Manager
  NIHR Research Delivery Network

  Patient-Centric Approaches Outsourcing & Clinical Trials

• 12:15
• 

• Smart use of GenAI, NLP and ML in Oncology Clinical Trials

  Experience the future of clinical trials with Science4Tech. Delve into the transformative power of GenAI, NLP, and ML as we revolutionize the landscape of oncology research. Experience firsthand how our cutting-edge AI solutions are reshaping the trial process, empowering life science companies to accelerate drug development while slashing both time and costs.

    Presentation

  ---

  

  Jordi Guitart Chief Executive Officer
  Science4Tech

  Clinical Trial Innovation Innovation and Technology Integration

• 12:40
• 

• Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths

  Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.

   

              

• 13:30
• 

• How clinical trials can utilise predictive ai to simulate a trial to predict its probability of success, and optimise the variables to increase success probability!

  ---

  

  Saurabh Jain Chief Executive Officer
  TrialKey

  Clinical Trial Innovation Innovation and Technology Integration

• 13:55
• 

• Quality considerations for the use of Real World Evidence in clinical development

    Presentation

  ---

  

  Andrew Gray Director, QA Clinical Therapeutic Area Head
  Johnson & Johnson

  Data and Real-World Evidence

• 14:25
• 

• Weighing and evaluating the outsourcing approach that is right for you

  • Flexible, and easy to implement model
  • Creating an effective strategy to decide when to outsource

  • Analysing the key risk factors your CRO might bring and how to tackle them
    Presentation

  ---

  

  Craig Elliott Director Strategic Alliance and Sourcing
  Merck Group

  Partnerships and Collaboration Outsourcing & Clinical Trials

• 14:55
• 

• EU PEARL, platform trials

    Presentation

  ---

  

  Nadir Ammour Global Lead, Clinical Innovation & External Partnership
  Sanofi

  Patient-Centric Approaches

• 15:25
• 

• Recharge with Tea or Coffee While Networking

  Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.

   

       

• 15:45
• 

• Africa’s role in reducing clinical delays

    Presentation

  ---

  

  Tina Barton Chief Operating Officer
  Emerging Markets Quality Trials (eMQT)

  

  Shalom Lloyd Co-Founder & Chief Strategy Officer
  Emerging Markets Quality Trials (eMQT)

  Partnerships and Collaboration

• 16:15
• 

• Interpretation and Impact of Real-World Clinical Data

  • Strategies for better decision-making
  • High-level models and simulations compelled by data will allow elimination of risky trials
  • The potential of real world data in clinical research goes past patient identification and patient recruitment

  ---

  

  Meelis Lootus Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group
  IEEE

  Data, Innovation & Technology Data and Real-World Evidence

• 16:45
• 

• Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas

  ---

  

  Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
  eMQT

  

  Meelis Lootus Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group
  IEEE

  

  Jennifer Eyerman Clinical Trial Partner, Clinical Operations, Research and Early Development
  Roche

  

  Andrew Gray Director, QA Clinical Therapeutic Area Head
  Johnson & Johnson

  

  Tina Barton Chief Operating Officer
  Emerging Markets Quality Trials (eMQT)

  Innovation and Technology Integration Data and Real-World Evidence Clinical Data & Tech Driven Clinical Trials

• 17:15
• 

• Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors

  • Working to create a positive, mutually beneficial environment and relationship between working partners.
  • Reaping the benefits of strategic collaborations to achieve efficiency, consistency, and reliability.
  • Achieving preferred providership with a sponsor company

  ---

  

  Dex Bilkic Director, Alliance Management
  AstraZeneca

  Partnerships and Collaboration

• 17:40
• 

• Chairperson’s Closing Remark

  End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.